Literature DB >> 7478592

The proline-rich region of Vav binds to Grb2 and Grb3-3.

F Ramos-Morales1, F Romero, F Schweighoffer, G Bismuth, J Camonis, M Tortolero, S Fischer.   

Abstract

Vav has structural features found in signaling proteins and is expressed only in hematopoietic cells. The recent development of mice Vav -/- has confirmed a major role of Vav in early blood cell development. We previously showed that Vav constitutively interacts with glutathione-S-transferase-Grb2. Coimmunoprecipitation experiments supported the idea of a complex formed by Vav-Grb2 in vivo. This complex is of potential interest in signaling of hematopoietic cells. In this work we localize the domains of Vav and Grb2 involved in this interaction. By the use of an in vivo genetic approach (the double hybrid system) and through in vitro experiments (glutathione-S-transferase fusion proteins) we furnish evidence that the interaction between Vav and Grb2 involves the C-SH3 domain of Grb2 and the proline-rich region located in the N-SH3 of Vav. Furthermore this was confirmed by the use of both Vav and Sos derived proline-rich peptides which blocked the binding. In addition we show that Vav also interacts with Grb3-3, a naturally occurring Grb2 isoform wich lacks functional SH2 domain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7478592

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

Review 1.  Regulatory and signaling properties of the Vav family.

Authors:  X R Bustelo
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation.

Authors:  L Zeng; P Sachdev; L Yan; J L Chan; T Trenkle; M McClelland; J Welsh; L H Wang
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  Solution structure of N-terminal SH3 domain of Vav and the recognition site for Grb2 C-terminal SH3 domain.

Authors:  Kenji Ogura; Koji Nagata; Masataka Horiuchi; Etsuko Ebisui; Tomoyo Hasuda; Satoru Yuzawa; Motohiko Nishida; Hideki Hatanaka; Fuyuhiko Inagaki
Journal:  J Biomol NMR       Date:  2002-01       Impact factor: 2.835

4.  Novel recognition mode between Vav and Grb2 SH3 domains.

Authors:  M Nishida; K Nagata; Y Hachimori; M Horiuchi; K Ogura; V Mandiyan; J Schlessinger; F Inagaki
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

5.  hSiah2 is a new Vav binding protein which inhibits Vav-mediated signaling pathways.

Authors:  A Germani; F Romero; M Houlard; J Camonis; S Gisselbrecht; S Fischer; N Varin-Blank
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

6.  Recruitment of the class II phosphoinositide 3-kinase C2beta to the epidermal growth factor receptor: role of Grb2.

Authors:  M Wheeler; J Domin
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

Review 7.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

8.  CD28 and Grb-2, relative to Gads or Grap, preferentially co-operate with Vav1 in the activation of NFAT/AP-1 transcription.

Authors:  Helga Schneider; Christopher E Rudd
Journal:  Biochem Biophys Res Commun       Date:  2008-02-22       Impact factor: 3.575

9.  p95vav associates with the nuclear protein Ku-70.

Authors:  F Romero; C Dargemont; F Pozo; W H Reeves; J Camonis; S Gisselbrecht; S Fischer
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

10.  GRIN1 regulates micro-opioid receptor activities by tethering the receptor and G protein in the lipid raft.

Authors:  Xin Ge; Yu Qiu; Horace H Loh; Ping-Yee Law
Journal:  J Biol Chem       Date:  2009-10-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.